A trial looking at calderasib for bowel cancer that has spread (KANDLELIT-012)

This trial is looking at calderasib, chemotherapy and cetuximab for bowel cancer that has spread. It is comparing this to having chemotherapy with or without bevacizumab.

It is open to people who:

• are having their first treatment for bowel cancer that has spread

• have a gene change (mutation) called KRAS G12C in their bowel cancer cells

You pronounce calderasib as kal-dair-ah-sib.